You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
For over 25 years, Medtronic has been a global leader in deep brain stimulation (DBS) device design and development.
And today, more than 175,000 Medtronic DBS devices have been implanted to treat Parkinson’s disease, epilepsy, essential tremor, and dystonia*.
View clinical research, understand patient selection, and discover why DBS is an important addition to the treatment continuum for the following indications.
DBS may be a therapeutic option for patients with recent or longer-standing motor complications.
Medtronic DBS for epilepsy gives patients a flexible, accessible therapy option that offers safe and effective seizure control.
Learn more about out how DBS works and how to identify candidates.
DBS may be considered when chronic, primary dystonia* symptoms can’t be successfully managed with medication.
This material is for Healthcare Professionals in countries with applicable health authority product registrations.
Important: Always refer to the Instructions For Use (IFU) packaged with the product/e-IFU for complete instructions, indications, contraindications, warnings, and precautions.
Humanitarian Device: Medtronic DBS Therapy has been authorized by Federal Law for the use as an aid in the management of chronic, intractable (drug refractory) primary dystonia and for people with chronic, severe, treatment-resistant obsessive-compulsive disorder. The effectiveness of this device for these uses has not been demonstrated.